sandoz-logo.jpg
Sandoz Supplemental Biologics License Application accepted by US FDA for biosimilar Hyrimoz® (adalimumab-adaz) high concentration formulation (HCF)
July 21, 2022 01:15 ET | Novartis Pharma AG
Submission supported by comprehensive analytical data package and clinical Phase I pharmacokinetics bridging study Proposed Hyrimoz® HCF would help expand access to medicine for patients with chronic...
NOVARTIS logo.jpg
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
June 22, 2022 20:01 ET | Novartis Pharma AG
Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against NTDs and malaria over five yearsCommitment includes USD...
Sandoz
Sandoz announces new global ‘Act4Biosimilars’ initiative, to improve patient access and increase adoption by at least 30% in 30+ countries by 2030
May 31, 2022 01:15 ET | Novartis Pharma AG
Multidisciplinary Steering Committee established to drive action includes patient advocacy leaders, healthcare professionals, biosimilar experts and industry leaders Action Plan will provide roadmap...
NOVARTIS logo.jpg
Novartis accelerates efforts toward ESG targets to increase access to medicines, improve health equity and achieve net-zero carbon emissions
September 30, 2021 01:15 ET | Novartis Pharma AG
Reached nearly 29 million patients to date in 2021 through our flagship programs and strategic innovative brandsAnnounced a planned 10-year commitment with historically black colleges and universities...
ModivCare Partners with the Michigan Department of Community Health and FEMA to Provide Critical Vaccine-Related Transportation to Ford Field
May 20, 2021 09:00 ET | ModivCare
Detroit, MI, May 20, 2021 (GLOBE NEWSWIRE) -- ModivCare Inc. (“ModivCare” or the “Company”) (Nasdaq: MODV), a technology enabled healthcare services company that provides a suite of integrated...
Maine Food Delivery Effort Turns to ModivCare for Support In Delivering Food to Students and Families in Aroostook County
March 08, 2021 09:00 ET | LogistiCare
Aroostook County, ME, March 08, 2021 (GLOBE NEWSWIRE) -- Melanie Lagasse, Food Service Director at Valley Unified Education Service Center (MSAD 27, MSAD 33 and Madawaska School Department)...
NOVARTIS logo.jpg
Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease
February 17, 2021 01:15 ET | Novartis International AG
Project brings together Novartis drug discovery and gene therapy expertise and funding support from the Gates Foundation  Agreement aims to address disparity in access to treatments and to prioritize...
sandos-logo.jpg
Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics
February 11, 2021 07:00 ET | Novartis International AG
Sandoz to acquire three established brands sold in more than 100 marketsAcquisition, including leading global brand Zinnat®, confirms Sandoz commitment to antibiotics, following plans to expand its...
ModivCare Delivers Free, Fresh Produce to Trenton Residents in Need
February 04, 2021 09:00 ET | LogistiCare
Trenton, NJ, Feb. 04, 2021 (GLOBE NEWSWIRE) -- ModivCare Solutions, LLC (“ModivCare”), formerly LogistiCare Solutions, LLC, the nation’s largest non-emergency medical transportation company and the...
NOVARTIS logo.jpg
Novartis hat 2020 Umsatz und Margen gesteigert und die nächste Welle von Medikamenten weiter vorangetrieben
January 26, 2021 01:00 ET | Novartis International AG
Der Nettoumsatz der fortzuführenden Geschäftsbereiche¹ stieg im Geschäftsjahr um 3% (kWk², +3% USD): Die Geschäftseinheit Pharmaceuticals wuchs um 5% (kWk), wozu vor allem Entresto (+44% kWk),...